Concepedia

Oral Anticancer Agents

Oral Anticancer Agents is a class of pharmacotherapeutic agents that belong to the broader category of anticancer drugs and are specifically formulated for oral administration, thereby distinguishing them from intravenous or parenteral chemotherapeutics by their route of delivery.

1.5K

Publications

79.8K

Citations

9.4K

Authors

2.1K

Institutions

Publications per year

2017–2026

408

Variants

Oral Antineoplastic Agents

Parents

Children

Publications

1.5K

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text

, , +16

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Sandrine Faivre, Catherine Delbaldo, Karina Vera et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text

, , +17

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Madeleine Duvic, Rakshandra Talpur, Xiao Ni et al. · Blood · 2006 · 1.1K citations · Full text

, , +13

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Elise A. Olsen, Youn H. Kim, Timothy M. Kuzel et al. · Journal of Clinical Oncology · 2007 · 1K citations

, , +16

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2019 · 922 citations · Full text

, , +15

1–5 of 1.5K

Authors

9.4K

  1. JH
    Jan H.M. Schellens

    The Netherlands Cancer Institute, Netherlands

    25 publications · 1.5K citations

    22

    h-index

  2. JH
    Jos H. Beijnen

    The Netherlands Cancer Institute, Netherlands

    24 publications · 1.5K citations

    20

    h-index

  3. HS
    Hiroshi Sakagami

    Meikai University, Japan

    30 publications · 1K citations

    19

    h-index

  4. HA
    Howard A. Burris

    Sarah Cannon, United States

    18 publications · 1.3K citations

    16

    h-index

  5. HR
    Hilde Rosing

    The Netherlands Cancer Institute, Netherlands

    19 publications · 1.5K citations

    16

    h-index

1–5 of 9.4K

Institutions

2.1K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    28 h-index

    219 publications

    27.9K citations

  2. The Netherlands Cancer Institute

    Amsterdam, The Netherlands

    24 h-index

    146 publications

    8.2K citations

  3. Utrecht University

    Utrecht, The Netherlands

    19 h-index

    38 publications

    1.8K citations

  4. Memorial Sloan Kettering Cancer Center

    New York, United States

    19 h-index

    113 publications

    28.4K citations

  5. Slotervaartziekenhuis

    Amsterdam, Netherlands

    18 h-index

    67 publications

    3.7K citations

  6. Institut Gustave Roussy

    Villejuif, France

    17 h-index

    92 publications

    28.1K citations

  7. Seoul National University

    Seoul, South Korea

    16 h-index

    79 publications

    2.1K citations

  8. China Medical University

    Taichung, Taiwan

    16 h-index

    66 publications

    2K citations

1–8 of 2.1K

Venues

  1. Journal of Clinical Oncology

    98 publications · 12K citations

    46

    h-index

  2. PubMed

    Repository · 159 publications · 7.1K citations

    42

    h-index

  3. Journal of Medicinal Chemistry

    33 publications · 2.9K citations

    28

    h-index

  4. Clinical Cancer Research

    32 publications · 3K citations

    25

    h-index

  5. Cancer Chemotherapy and Pharmacology

    47 publications · 2.1K citations

    24

    h-index

1–5